Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 12, 2026
TickeronGET DAILY SIGNALS
Aramark (ARMK): What to Expect from Q2 Fiscal 2026 Earnings

Aramark (ARMK): What to Expect from Q2 Fiscal 2026 Earnings

Key Takeaways

  • Analysts expect Q2 fiscal 2026 revenue of approximately $4.76 billion, reflecting about 11% year-over-year growth.
  • Consensus adjusted EPS estimate stands at $0.47-$0.48 per share, implying strong 38%-41% growth from prior year.
  • Company reaffirmed FY2026 guidance for 7%-9% organic revenue growth and adjusted EPS of $2.18-$2.28.
  • Key focus on FSS United States and International segments, with calendar shift tailwind anticipated for Q2.
  • Robust net new business pipeline supports outlook, targeting 4%-5% growth for the full year.
  • Investors watching margins amid food cost inflation and new contract ramps.

Earnings Context and Why It Matters

As someone who follows the food services and facilities management space closely, I see ARMK as a steady player navigating a competitive environment driven by demand from education, healthcare, and business sectors. This upcoming Q2 fiscal 2026 earnings report, set for today, May 12, 2026, feels particularly important. It comes on the heels of a strong Q1, where revenue reached $4.83 billion, up 6% year-over-year, even with a headwind from the fiscal 2025 53rd week calendar shift. From what I see, investors will be looking for signs of continued organic growth, new business wins, and steady progress toward full-year goals, especially as inflation moderates and business & industry (B&I) volumes recover. Solid results here could further validate the company's multi-year turnaround efforts.

Earnings Expectations

Wall Street's projections point to consolidated revenue of around $4.76 billion for Q2 fiscal 2026, which ended roughly in April 2026, marking about 11% growth from the $4.33 billion reported in the year-ago quarter. The consensus for adjusted EPS sits at $0.47 to $0.48, representing a 38%-41% jump from $0.34 last year, fueled by operational leverage and contributions from new business. Expectations break down to FSS United States revenue at $3.39 billion (up 10.9%) and FSS International at $1.39 billion (up 14%).

Q1 demonstrated real resilience: organic revenue grew 5% to a total of $4.8 billion, adjusted EPS held flat at $0.51 (which would have been up 13% without the shift), and adjusted operating income (AOI) rose 1%. Management has flagged a tailwind for Q2 from that prior 53rd week shift. The full-year guidance remains unchanged: revenue of $19.55-$19.95 billion (7%-9% organic growth), AOI growth of 12%-17%, adjusted EPS of $2.18-$2.28 (20%-25% growth), and leverage below 3.0x (net debt to AOI). I'll be paying close attention to net new business (targeting 4%-5%), client retention rates, and margins in the face of food and labor cost pressures.

Market Reaction and Investor Sentiment

One thing that stands out to me is the cautiously optimistic sentiment around ARMK heading into these results. Shares have held up well since the Q1 revenue and EPS beats, posting modest gains even amid broader market swings. Analysts highlight upside potential in B&I and education volumes, though risks like contract delays or inflation-driven margin squeezes remain on the radar. Historically, the stock has reacted positively to beats—for instance, up 2% after-hours following Q1—though reaffirmation of guidance will likely be the deciding factor. Options pricing suggests limited volatility is baked in.

AI Screener: A Tool I Rely On for Peers Comparison

I also checked this using Tickeron’s AI Screener to see how ARMK stacks up against peers on technical patterns, fundamentals, and trends. This AI-powered tool scans thousands of stocks and ETFs with customizable filters like industry, market cap, and performance metrics, helping pinpoint opportunities more efficiently than manual reviews. In my view, it's a practical way to enhance analysis without the guesswork—worth exploring if you're screening for similar names.

Forward Outlook and Key Factors to Monitor

In my view, Aramark's reaffirmed FY2026 guidance signals real confidence, with organic revenue growth targeted at 7%-9% and adjusted EPS expanding 20%-25% to $2.18-$2.28. This outlook builds directly on Q1 momentum, including net new business wins in healthcare (such as RWJ Barnabas), education, corrections, sports, and mining, plus record retention above 95%.

I'm watching Q2 progress toward the 4%-5% net new business target closely, backed by a strong pipeline where over 40% comes from first-time outsourcing. The calendar shift tailwind should support FSS United States revenue growth, particularly in B&I and higher education.

Other elements to track include AI-driven efficiencies in the supply chain, group purchasing organization (GPO) spend surpassing $20 billion, and recent debt repricings that lower interest expenses. Keep an eye on cost trends—food and labor inflation is tracking plans—and progress toward leverage under 3.0x. With upcoming contract ramps and 17 straight quarters of double-digit international growth, these results will offer insight into demand resilience in an uncertain economy.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: ARMK

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARMK in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 05, 2026

ARMK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 37 cases where ARMK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARMK's RSI Indicator exited the oversold zone, 17 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 57 cases where ARMK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on ARMK as a result. In 67 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

Following a +8.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARMK advanced for three days, in 202 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ARMK turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 22 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARMK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

The Aroon Indicator for ARMK entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. ARMK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.081) is normal, around the industry mean (5.887). P/E Ratio (36.234) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.845) is also within normal values, averaging (1.946). Dividend Yield (0.009) settles around the average of (0.025) among similar stocks. P/S Ratio (0.776) is also within normal values, averaging (9.907).

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 8.05B. The market cap for tickers in the group ranges from 47.27K to 88.84B. CTAS holds the highest valuation in this group at 88.84B. The lowest valued company is KUBR at 47.27K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was 19%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 1%. SMX experienced the highest price growth at 447%, while LICN experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 30%. For the same stocks of the Industry, the average monthly volume growth was 106% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 58
Price Growth Rating: 56
SMR Rating: 73
Profit Risk Rating: 83
Seasonality Score: 15 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company with interests in food services and facilities management

Industry OfficeEquipmentSupplies

Industry
Restaurants
Address
2400 Market Street
Phone
+1 215 238-3000
Employees
278390
Web
https://www.aramark.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AquaBounty Technologies, Inc. (NASDAQ: AQB) has no credible, current sell-side price targets. With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.